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Histologic Findings in Mucosa and Muscularis Propria 
Biopsied During Peroral Endoscopic Myotomy  
in Patients With Achalasia
Xiuli Liua, d, Enoch Kuob, Kai Wangb, Yassen B. Perbtanic,  
Dennis Yangc, Peter Draganovc
Abstract
Background: Peroral endoscopic myotomy (POEM) has been in-
creasingly used to treat achalasia. Previous studies have reported 
high frequency of muscular eosinophilic infiltration in achalasia. 
Esophageal mucosal changes in achalasia have only been studied in 
esophagectomy specimens. Cardia mucosal changes in achalasia have 
not been reported previously. We aimed to further characterize the es-
ophageal, gastric cardia, and muscularis propria changes in achalasia.
Methods: This was a pilot study. Patients with clinically and radio-
graphically confirmed achalasia who underwent POEM were enrolled 
in the study. Mucosal biopsies were taken 1 cm proximal and 1 cm 
distal to the gastroesophageal junction, and muscularis propria biop-
sies were taken from the mid esophagus. Tissues were submitted for 
histological evaluation.
Results: Eighteen patients (10 male and eight female, mean age: 60.7 
(standard deviation (SD): 13) years) were enrolled in this pilot study. 
Nine patients had type II achalasia, two type III, one type I, five es-
ophageal gastric outlet obstruction, and one unspecific type achalasia. 
The mean duration of symptoms prior to POEM was 79 (range 1 - 
480) months. All patients had a dilated esophagus on examination, 
but no endoscopic evidence of Barrett’s esophagus. Esophageal, gas-
tric cardia, and muscular biopsies were performed in 17, 13, and 17 
patients, respectively. Basal hyperplasia, spongiosis, ballooning, and 
parakeratosis were seen in 92.3%, 100%, 100%, and 76.5% of cas-
es, respectively. Intraepithelial lymphocytosis was seen in 70.5% of 
cases, and active esophagitis was seen in 23.5% of case. Six (35.3%) 
cases had few intraepithelial eosinophils, but none of them had > 15 
eosinophils per high power field. Histologic findings in gastric car-
dia mucosa included carditis (69.2%), H. pylori gastritis (7.6%), and 
reactive gastropathy (15.4%). One case (7.6%) showed low-grade 
dysplasia arising from intestinal metaplasia in the cardia. Absence of 
ganglion cells in the muscular biopsies was noted in 88.2% of cases, 
and the remaining two showed rare residual ganglion cells with gan-
glionitis in one case (5.8%). Muscular atrophy and interstitial fibrosis 
were observed in 52.9% and 82.3% of the cases, respectively. Two 
cases (11.7%) had eosinophilic inflammation in the muscularis pro-
pria and one of them was accompanied by lymphocytic inflammation.
Conclusions: Muscular biopsies in our study revealed loss of gan-
glion cells, supporting the view that achalasia is a primary esophageal 
disease with ganglion cell depletion. Squamous mucosa in achalasia 
showed changes mimicking reflux and lymphocytic esophagitis. Car-
dia mucosa in achalasia patients often were inflamed and uncommon-
ly showed intestinal metaplasia and glandular dysplasia.
Keywords: Achalasia; Eosinophilic esophagitis; Ganglion cell; Lym-
phocytic esophagitis; Peroral endoscopic myotomy
Introduction
Achalasia is a rare disease characterized by aperistalsis of the 
esophageal body and failure of the lower esophageal sphinc-
ter to relax with attempted swallowing. Patients with achalasia 
typically present with dysphagia. Diagnosis is often made by 
timed barium esophagram, high-resolution manometry and en-
doscopy. Treatment options for symptomatic achalasia include 
botulinum toxin injection, pneumatic balloon dilation and en-
doscopy or surgical myotomy.
The etiology of achalasia remains largely unknown. In 
some patients with achalasia, myenteric inflammation has 
been associated with eosinophilic/lymphocytic infiltration of 
the esophageal muscle in resected esophagectomy or myotomy 
specimens [1-3]. Other common findings include severe fibro-
sis and obvious myopathic changes of the smooth muscle cells 
[3]. However, the significance of these findings has not been 
corroborated in large patient population studies, particularly 
in the early stage of disease or in patients treated endoscopi-
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cally before the development of end stage achalasia. It is well 
known that both eosinophilic and lymphocytic esophagitis, 
characterized by infiltration of eosinophils and lymphocytes in 
the mucosa, can manifest clinically with dysphagia. Whether 
eosinophilic/lymphocytic mural infiltration of the muscle layer 
of the esophagus is routinely present and plays a role in acha-
lasia remains to be determined [4, 5]. Recent literature sug-
gests an association of achalasia with eosinophilic esophagitis 
[4].
Peroral endoscopic myotomy (POEM) has become a 
standard endoscopic therapy of achalasia [6]. During the 
POEM procedure, biopsy of the mucosa and the muscle layer 
of the esophagus can be easily obtained. We hypothesize that 
eosinophilic/lymphocytic esophagitis and achalasia poten-
tially represent spectrums of the same condition. The aim of 
the study was to examine the eosinophilic and lymphocytic 
infiltration in esophageal mucosa and muscle on biopsy taken 
simultaneously during POEM procedure done for therapy of 
clinically and radiographically confirmed achalasia as part of 
routine patient care.
Materials and Methods
All adult patients (age 18 years or older) who were scheduled 
to undergo POEM at the University of Florida as part of their 
routine care were eligible for the study. The diagnosis of acha-
lasia was attained based on high-resolution manometry find-
ings according to the Chicago Classification of esophageal 
motility disorders along with endoscopic and radiographic 
findings. Exclusion criteria included: 1) any contraindication 
to perform endoscopy, 2) participation in another research pro-
tocol that could interfere or influence the outcomes measures 
of the present study, and 3) if the subject was unable/unwilling 
to give informed consent. The study was approved by the In-
stitutional Research Board (IRB) at University of Florida. This 
study was conducted in compliance with the ethical standards 
of the responsible institution on human subjects as well as with 
the Helsinki Declaration.
Biopsy and tissue handling protocol
Biopsies of the esophageal mucosa (1 cm proximal to the gas-
troesophageal junction (GEJ)), gastric cardia mucosal biopsy 
(1 cm distal to the GEJ) were performed during the endos-
copy for POEM. Biopsies of the muscularis propria at the mid 
esophagus level were performed after completion of the es-
ophageal myotomy during POEM and prior to closure of the 
mucostomy.
The tissue specimens were fixed in formalin and em-
bedded in paraffin and two 5-µm sections were stained with 
hematoxylin and eosin (H&E). The mucosal biopsies were 
analyzed for basal hyperplasia, elongation of papillae, spon-
giosis, ballooning, parakeratosis, squamous dysplasia, inflam-
mation (peripapillary intraepithelial lymphocytes, interpapil-
lary intraepithelial lymphocytes, neutrophil, eosinophil (peak 
and average), subepithelial fibrosis, subepithelial inflamma-
tion, presence or absence of columnar epithelium, presence 
or absence of intestinal metaplasia, presence or absence of 
glandular dysplasia. The muscular biopsies were evaluated 
for smooth muscle atrophy, hypertrophy, anisocytosis, calci-
fication, vacuolization, interstitial fibrosis, inflammation (eo-
sinophil and lymphocyte), ganglionitis, neuritis, peri-vascular 
inflammation or intra-vascular inflammatory cell margination, 
presence or absence of ganglion cells. The histologic review 
was conducted using previously published methods with some 
modifications [2, 7-9]. Intraepithelial lymphocytosis was de-
fined as more than 20 intraepithelial lymphocytes (IELs) per 
high power field (HPF) [10]. Definitions of histologic features 
evaluated in this study are listed in Tables 1 and 2. Data are 
presented as range (minimum - maximum) or mean ± stand-
ard deviation (SD). Continuous data were compared with Stu-
dent’s t-test with significance setting at P < 0.05.
Results
Demographics of study population
Eighteen patients with achalasia were prospectively enrolled 
from June 2019 to June 2020 after providing informed con-
sent in this pilot study. Clinical features and demographics of 
enrolled patients are summarized in Table 3. Eighteen patients 
(10 male and eight female, mean age: 60.7 (SD: 13; range 
34 - 81) years) with achalasia were prospectively enrolled in 
this study. All patients had high-resolution manometry. Nine 
patients had type II achalasia, two type III, one type I, five 
esophageal gastric outlet obstruction, and one unspecific type 
achalasia. The mean duration of achalasia was 79 (SD: 114; 
range: 1 - 480) months. Two (11.0%) patients had prior my-
otomy. Eleven (of 18, 61.1%) patients were on proton pump 
inhibitors (PPIs) (omeprazole 40 mg daily in six, 40 mg bid 
in three, lansoprazole 15 mg daily in one and PPI unspecified 
in one). Baseline timed barium esophagram was performed in 
17 out of the 18 patients and revealed dilated esophagus in 
six patients, dilated esophagus with delayed passage of barium 
in seven, and normal examination in four. All patients had a 
dilated esophagus on endoscopic examination, two patients 
had esophagitis and one with diverticulum, but none of them 
showed salmon-colored mucosa endoscopically. POEM was 
successfully completed in all of the patients without any com-
plications.
Histologic findings in esophageal mucosal biopsies
Esophageal biopsies at the mid esophagus level were per-
formed in 17 patients. The number of esophageal biopsy frag-
ments ranged from 1 to 5 (median 3). The esophageal biop-
sy showed similar changes as summarized in Table 4. Basal 
hyperplasia, spongiosis, ballooning, and parakeratosis (Fig. 
1a) were seen in 92.3%, 100%, 100%, and 76.5% of cases, 
respectively. Mean peripapillary IELs and intrapapillary IELs 
were 37 (SD 29) and 22 (SD 21) per HPF, respectively. Twelve 
(70.5%) cases had intraepithelial lymphocytosis (defined as > 
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Table 1.  Definitions of Histologic Features Evaluated in the Mucosal Biopsies
Features Definition Cutoff value
Squamous
  Basal hyperplasia Thickening of basal layers of squamous epithelium Presence or absence
  Elongation of papillae Height of papillae > 50% of epithelium thickness Presence or absence
  Spongiosis Widening of intercellular spaces due to edema Presence or absence
  Ballooning degeneration Enlarged squamous cells with intracellular edema Presence or absence
  Parakeratosis Superficial layers of nucleated squamous 
cells with dense keratin
Presence or absence
  Dysplasia Neoplastic squamous epithelium confined 
above the basement membrane
Presence of absence
Inflammation within the squamous mucosa
  Peripapillary IEL IELs in the first five layers of squamous epithelium 
surrounding the esophageal papillae
Number of IELs per high-
power field in the most 
densely infiltrated fields
  Interpapillary IEL IELs in the squamous epithelium beyond 
the peripapillary regions
Number of IELs per high-
power field in the most 
densely infiltrated fields
  Neutrophil Neutrophils in squamous epithelium Presence or absence
  Eosinophil Eosinophils in squamous epithelium Number of eosinophils per 
high-power field in the most 
densely infiltrated fields
Columnar Glandular epithelium Presence or absence
  Intestinal metaplasia Goblet cells Presence or absence
  Glandular dysplasia Neoplastic glandular epithelium confined 
above the basement membrane
Presence or absence
Subepithelial fibrosis Increased collagen deposition underneath the epithelium Presence or absence
Submucosal inflammation Inflammatory cells in the submucosa Presence or absence
IEL: intraepithelial lymphocytosis; IELs: intraepithelial lymphocytes.
Table 2.  Definitions of Histologic Features Evaluated in Muscular Biopsies
Features Definition Cutoff value
Smooth muscle
  Atrophy Thin and small smooth muscle fibers Presence or absence
  Hypertrophy Thick and large smooth muscle fibers Presence or absence
  Calcification Purple amorphous deposition in the tissue Presence or absence
Interstitial fibrosis Increased collagen fiber Presence or absence
Myenteric plexus
  Ganglion cells Neuron Presence or absence
  Ganglionitis Lymphocytic infiltration into ganglion cell cytoplasm Presence or absence
  Neuritis Inflammation within or immediately around myenteric nerves Presence or absence
Inflammation
  Intramuscular eosinophil Eosinophilic infiltration in smooth muscle fibers Presence or absence
  Intramuscular lymphocytes Lymphocytic infiltration in smooth muscle fibers Presence or absence
  Perivascular inflammation Inflammatory cells in the perivascular spaces Presence or absence
  Intravascular margination 
of inflammatory cells
Inflammatory cells in the vascular spaces Presence or absence
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20 IELs per HPF) including eight cases with peripapillary and 
interpapillary lymphocytosis, two peripapillary intraepithe-
lial lymphocytosis and two interpapillary lymphocytosis only. 
Peripapillary lymphocytosis was not associated with the use 
of PPI (37 ± 34 IELs/HPF in patients taking PPIs vs. 33 ±321 
IELs/HPF in patients not taking PPIs, P = 0.77). Interpapillary 
lymphocytosis was not associated with the use of PPI either 
(27 ± 25 IELs/HPF in patients taking PPIs vs. 14 ±110 IELs/
HPF in patients not taking PPIs, P = 0.26). Active esophagitis 
was seen in 23.5% of case. Six (35.3%) cases had few intraepi-
thelial eosinophils (Fig. 1b), but none of them had > 15 eosino-
phils per HPF. Subepithelial inflammation and fibrosis were 
seen in 33.0% and 41.6% of cases, respectively. No squamous 
dysplasia was noted in any cases.
Histologic findings in gastric cardia biopsies
Gastric cardia biopsies were performed in 13 patients. The 
number of gastric cardia mucosal biopsy fragment ranged 
from 1 to 2 (median: 1). Histologic findings in gastric cardia 
mucosa included carditis (69.2%) (Fig. 2a), H. pylori gastritis 
(7.6%), and reactive gastropathy (15.4%) (Table 4). One case 
(7.6%) had low-grade dysplasia (Fig. 2b) arising from intesti-
nal metaplasia in the cardia which showed moderate chronic 
inactive carditis. No H. pylori organisms were seen on H&E-
stained section in this case, but special stain or immunostain 
was not performed for H. pylori.
Histologic findings in muscular biopsies
Muscular biopsies were performed in 17 patients. The number 
of muscular biopsy fragments ranged from 1 to 4 (median: 2). 
The muscular biopsies showed similar changes in the study 
population and the results are summarized in Table 4. Absence 
of ganglion cells in the muscular biopsies was noted in 88.2% 
of cases, and the remaining two showed rare residual ganglion 
cells with ganglionitis and neuritis in one case (5.8%). Mus-
cular atrophy and interstitial fibrosis (Fig. 3a) were observed 
in 52.9% and 82.3% of cases, respectively. Two cases (11.7%) 
had eosinophilic inflammation in the muscularis propria (Fig. 
3b) and one of them was accompanied by lymphocytic inflam-
mation. In these two cases, up to 25 and 50 eosinophils per 
Table 3.  Clinical Characteristics of Achalasia Patients
Feature
Gender (male/female) 10:8
Age (mean, SD, range) (years) 60.7 (13), 34 - 81
Duration of achalasia (mean, SD, range) (months) 79 (114), 1 - 480
Type of achalasia (N = 18), N (%)
  Type I 1 (5.6)
  Type II 9 (50.0)
  Type III 2 (11.0)
  Esophageal gastric outlet obstruction 5 (27.8)
  Unspecified type 1 (5.6)
Prior myotomy, N (%) 2 (11.0)
Endoscopic findings (N = 18), N (%)
  Dilated esophagus only 15 (83.3)
  Dilated esophagus with esophagitis 2 (11.1)
  Dilated esophagus with diverticulum 1 (5.6)
Timed barium study (N = 17), N (%)
  Dilated esophagus 6 (35.3)
  Dilated esophagus with delayed passage of barium 7 (41.2)
  Normal examination 4 (23.5)
PPI use (N = 18), N (%)
  Omeprazole 40 daily 6 (33.3)
  Omeprazole 40 mg bid 3 (16.7)
  Lansoprazole 15 mg daily 1 (5.6)
  Unspecified 1 (5.6)
  None 7 (38.8)
SD: standard deviation; PPI: proton pump inhibitor.
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HPF were noted in the muscularis propria. One patient had 
esophageal gastric outlet obstruction for 1 year and the other 
patient had type III achalasia for 40 years. Five (29.4%) cases 
showed focal and mild perivascular inflammatory infiltrate or 
intravascular inflammatory cell margination but without evi-
dence of vasculitis. None of the muscular biopsies showed any 
calcification.
Discussion
Achalasia is a rare disease defined by aperistalsis of the es-
ophageal body and failure of the lower esophageal sphincter to 
relax with attempted swallowing. Patients with achalasia typi-
cally present with dysphagia which may also be accompanied 
by other symptoms. Although advances in the diagnosis and 
treatment of achalasia have been made over the last decade, 
the etiology of achalasia remains elusive. This is partly due to 
the lack of knowledge on the histologic changes in early-stage 
achalasia. Histologic examination of esophagectomy and open 
Heller myotomy specimens have shown myenteric inflamma-
tion, ganglion cell loss, and eosinophilic/lymphocytic infil-
tration of the esophageal muscle in achalasia [1, 3]. Similar 
changes have been reported in deep muscle strips obtained dur-
ing open Heller myotomy [2]. Other common findings include 
severe fibrosis and obvious myopathic changes of the smooth 
muscle cells [3]. However, the significance of these findings 
has not been corroborated in large patient population studies, 
particularly in early stage of disease or in patients treated en-
doscopically before the development of end-stage achalasia. 
This pilot study was carried out to examine myenteric plexus 
and muscular changes in achalasia patients undergoing POEM 
to obtain a snapshot view of the histologic changes at a stage 
earlier than those in esophagectomy and/or open Heller myot-
omy specimens as reported in previous studies. Notably, recent 
literature has suggested an association of achalasia with eo-
sinophilic esophagitis [4]. As such, we also hypothesized that 
eosinophilic/lymphocytic infiltration of the esophageal wall 
layers could play a role in different disease processes, with 
eosinophilic/lymphocytic esophagitis and achalasia potentially 
representing spectrums of the same condition.
Muscular biopsies in our study revealed loss of ganglion 
cells in most cases, which is in line with previous reports in 
esophagectomy or myotomy specimens [1-3]. Interestingly, in 
our study, ganglionitis and neuritis was only noted in one case, 
albeit few ganglion cells were still present. This is in contrast 
to the high frequency of neuritis reported in other studies on 
esophagectomy and myotomy specimens [1, 2]. We speculate 
that the discrepancy may have been due to the stage of achalasia, 
type of specimens (resection vs. small biopsy), and sample level 
(distal vs. mid esophagus). The mean duration of achalasia in 
our patient population was 79 months, longer than the 14-month 
duration of disease in two studies showing more prominent in-
flammation in myotomy specimens [2, 11]. Sampling level (dis-
tal vs. mid esophagus) may not be the main reason as loss of 
ganglion cells and inflammation in myenteric plexus have been 
noted in the mid and distal esophagus in esophagectomy speci-
mens [1]. However, the small size of muscular biopsy taking 
during POEM in the current study may have missed the area 
which was more inflamed. One recent study on esophageal near-
ly full-thickness muscle sample reported loss of Schwann cell 
loss which was more profound in achalasia type I and in the mid 
Table 4.  Esophageal, Gastric Cardia, and Muscular Biopsy Findings in Patients With Achalasia Undergoing Peroral Endoscopic 
Myotomy
Mucosal biopsy findings Feature N (%)




Intraepithelial lymphocytosis 12 (70.5)
Neutrophilic inflammation 4 (23.5)
Eosinophilic inflammation 3 (35.3)
Gastric cardia mucosa (N = 13) Carditis 9 (69.2)
H. pylori gastritis 1 (7.6)
Reactive changes 2 (15.4)
Intestinal metaplasia 1 (7.6)
Low-grade dysplasia 1 (7.6)
Muscular biopsy findings (N = 17) Absence of ganglion cells 15 (88.2)
Ganglionitis 1 (5.8)
Muscular atrophy 9 (52.9)
Interstitial fibrosis 14 (82.3)
Eosinophilic inflammation 2 (11.7)
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esophageal muscular biopsies [12]. However, this study did not 
report the status of ganglion cells in these muscular biopsies or 
duration of achalasia in these patients.
Focal and mild perivascular and/or intravascular margina-
tion of inflammatory cells were noted in 29.4% of the cases 
in this study. Similar findings were illustrated in 28.6% of 
muscular biopsies taken during POEM in a recently published 
study [13] and in 17% of muscular biopsies obtained during 
laparoscopic myotomy surgery [14]. In contrast to the high 
rate of eosinophilic inflammation in the muscularis externa re-
ported by Jin et al [13], we only identified mild eosinophilic 
infiltration (up to 25 and 50 eosinophils per HPF) in 11.7% of 
the cases. The reasons for the discrepancy between the current 
and previous studies may include different stage of achalasia, 
specimen type, biopsy level (lower esophageal sphincter, distal 
esophagus proximately 5 cm above the EGJ, and mid esopha-
gus (about 10 - 20 cm above the EGJ)) vs. mid esophagus only 
in the current study), and composition of different achalasia 
types/subsets. One study suggested the presence of two subsets 
of achalasia with one subset with T-cell-rich inflammation in 
the myenteric plexus and one subset with greater loss of nerve 
fibers but without much inflammation [15]. The latter subset 
were comprised of patients with shorter duration of achalasia 
(6.4 years), suggesting a more aggressive disease [15]. The 
mean duration of achalasia in our patient population was 79 
months, similar to the subset of achalasia with more aggres-
sive disease [15], longer than the 14-month duration of disease 
in two studies showing more prominent inflammation in my-
otomy specimens [2, 11], shorter than the 10-year duration of 
disease who underwent esophagectomy [11]. One additional 
study of muscular biopsy obtained during laparoscopic myoto-
my surgery revealed different histopathologic patterns among 
achalasia subtypes with type I showing more prominent gan-
glion cell loss than type II [14]. The discrepancy may also be 
due to different patient population (Chinese vs. United States) 
and different definitions of muscularis propria/muscularis ex-
terna. Exact definitions of muscularis externa and muscularis 
propria were not given in the study by Jin et al [13]. Generally 
speaking, muscularis externa and muscularis propria refer to 
similar layer of esophagus, i.e., the muscle between the sub-
mucosa and the adventitia. It is not clear why the authors spe-
Figure 2. Finding in muscular biopsy in achalasia. (a) Interstitial fibro-
sis in the muscular biopsy (H&E stain, × 100). (b) Interstitial fibrosis 
and elastosis and absence of ganglion cells in the muscular biopsy. 
The fibrosis/elastosis is accompanied by mild eosinophilic inflammation 
(H&E stain, × 200).
Figure 1. Mucosal changes in mid esophageal biopsy from one patient 
with achalasia who underwent peroral endoscopic myotomy. (a) Peri-
papillary edema (spongiosis) and ballooning are noticeable (H&E stain, 
× 100). (b) Intraepithelial lymphocytosis is present (H&E stain, × 200).
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cifically examined and reported eosinophilic infiltration in the 
muscularis propria and muscularis externa in that study [13].
In addition to the finding of ganglion cell loss in achalas-
ia, the current study revealed muscular atrophy and fibrosis in 
52.9% and 80% of cases. This is consistent with one previous 
study which reported a severe fibrosis of the smooth muscle 
layer in 10 of 17 cases and obvious myopathic changes of the 
smooth muscle cells in five of 17 cases [3].
It is well known that both eosinophilic and lymphocyt-
ic esophagitis, characterized by infiltration of eosinophils 
and lymphocytes in the mucosa, can manifest clinically with 
dysphagia. Whether eosinophilic/lymphocytic mural infiltra-
tion of the muscle layer of the esophagus is routinely present 
and plays a role in achalasia remains to be determined [4, 5]. 
Recent literature suggests an association of achalasia with 
eosinophilic esophagitis [4]. Mucosal changes at the time of 
POEM have not been studied. Our study aimed to evaluate the 
mucosal findings in the esophagus and gastric cardia immedi-
ately prior to POEM. The squamous mucosa biopsies showed 
a pattern of lymphocytic esophagitis, i.e., basal hyperplasia, 
papillary elongation, spongiosis, ballooning, and intraepithe-
lial lymphocytes in 70.5% cases, resembling gastroesophageal 
reflux disease (GERD)-associated esophageal mucosa changes 
[8], and in line with a previous study of mucosal changes in 
the esophagectomy specimens for end-stage achalasia [3, 7]. 
This change may likely be due to stasis, although it resem-
bles squamous changes in GERD. Lymphocytic inflammation 
in the muscular biopsy was only encountered in 5.8% of the 
cases in our study, which is much lower than the 70.5% of 
mucosal intraepithelial lymphocytosis rate, indicating a mu-
cosa-accented lymphocytic inflammation in achalasia, likely 
secondary to stasis.
A few recent reports suggest that achalasia may be associ-
ated with eosinophilic esophagitis [4, 13]. None of our cases 
showed mucosal eosinophilic inflammation to the level of eo-
sinophilic esophagitis or diffuse eosinophilic inflammation in 
the muscular propria, suggesting that eosinophilic esophagitis 
is not likely the reason/etiology for/of majority of achalasia 
cases. However, the small size of our study does not rule out 
eosinophilic esophagitis as the etiology of achalasia in rare 
cases. Long-term clinical and manometric follow-up patients 
with eosinophilic esophagitis may provide a more definitive 
answer in the future.
Achalasia is a risk factor of squamous cell carcinoma [1, 
16-19] and an increased frequency of p53 immunoreactivity 
has been reported in the esophageal mucosa in patients with 
late-stage achalasia [7]. Nonetheless, none of our patients 
showed squamous dysplasia, but this may have been precluded 
by the small sample size in this pilot study.
Gastric cardia was biopsied in 13 cases in the current study. 
No antrum or gastric body mucosa biopsies were obtained. 
Histologic findings included carditis (69.2% of patients), H. 
pylori gastritis (7.6% of patients), and reactive gastropathy 
(15.4% of patients). The prevalence of H. pylori gastritis was 
similar to the general population in the USA [20]. The etiology 
and mechanism of carditis in achalasia remains unclear. The 
peak acid output has been shown to be significantly lower in 
achalasia patients along with loss of Auerbach’s plexus in the 
body of the stomach [21]. One case in our study (7.6%) had 
low-grade dysplasia arising from intestinal metaplasia in the 
cardia with moderate chronic inactive carditis in the absence of 
H. pylori organisms on H&E-stained section. No special stain 
or immunostain was performed for H. pylori in this case, so H. 
pylori gastritis-associated intestinal metaplasia-dysplasia can-
not be completely ruled out. Achalasia secondary to malignan-
cy in the cardia/esophagus is a well-known phenomenon; how-
ever, our current finding of low-grade dysplasia in the cardia in 
patients with achalasia suggests that “secondary” achalasia in 
cases with cardia/esophageal adenocarcinoma may be primary 
or idiopathic in some cases. Low-grade glandular dysplasia in 
this study was most likely of cardia origin rather than esopha-
geal origin (i.e., Barrett’s esophagus) as there was no endo-
scopic evidence of Barrett’s esophagus. Interestingly, 61.1% 
of patients were on PPIs at the time of POEM but only two 
patients had prior myotomy procedures. Our results suggest 
that biopsies of the stomach and esophageal mucosa at the time 
of POEM or before POEM should be performed to diagnose 
H. pylori infection and detect carditis, intestinal metaplasia, 
and dysplasia in these patients, albeit future studies are needed.
None of our patients had complications after cold biopsy 
and POEM. This is consistent with previous studies that the 
Figure 3. Histologic findings in the gastric cardia in achalasia. (a) Gas-
tric cardia with mild chronic carditis (H&E stain, × 100). (b) Moderate 
chronic carditis with intestinal metaplasia and focal low-grade dysplasia 
(H&E stain, × 100).
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estimated risk of bleeding during or after biopsy is 0.002%, 
extremely low [22]. Our results indicate that muscular biopsy 
is safe and may be used in patients who undergo POEM. Our 
results demonstrated that loss of ganglion cells was identi-
fied in most achalasia cases, suggesting that muscular biopsy 
obtained during endoscopy was adequate to study myenteric 
plexus and muscularis propria in achalasia. This muscular bi-
opsy approach may be used in achalasia patients shortly after 
the onset of symptoms to obtain high-quality near full-thick-
ness neuromuscular biopsies. Information on earlier changes 
in the myenteric plexus and muscularis propria in achalasia is 
essential for understanding the pathogenesis and may poten-
tially yield effective medical non-invasive treatment strategies.
Our current study has several strengths and limitations. First, 
this is the first study to examine the esophageal mucosa, gastric 
cardia, and muscular biopsy in achalasia. Second, the muscular 
biopsy was done endoscopically at the time of POEM. Third, 
the histology was read by a gastrointestinal pathologist with an 
interest in esophageal diseases. One of the main limitations is the 
small size of the cohort which was partly due to the disruption of 
enrollment as a result of the COVID-19 pandemic. Another limi-
tation was the lack of a normal control group for the muscular 
biopsy. However, biopsy of deep muscle in the esophagus in pa-
tients without an indication appears to be unethical. In addition, 
there are several previous studies examining normal esophageal 
muscle from the histologically normal esophageal segment from 
the esophagectomy performed for carcinoma [2, 13].
In summary, the current study demonstrated the feasibility 
and safety of deep muscle biopsy prior to POEM. Absence of 
ganglion cells was noted in the majority of achalasia patients 
undergoing POEM suggesting that our study patients were 
closer to end-stage disease, rather than early stage. Eosino-
philic inflammation was only present in a minority of acha-
lasia muscular biopsies and often of mild degree suggesting 
eosinophilic inflammation was not a driving force leading to 
achalasia in most cases. Achalasia-associated mucosal changes 
include a lymphocytic esophagitis pattern and chronic carditis 
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